| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.3M | +27.5% |
| Cost of Revenue | $12.0M | +23.1% |
| Gross Profit | $41.3M | +28.8% |
| R&D Expense | $2.3M | +19.6% |
| SG&A Expense | $10.7M | +9.5% |
| Operating Income | $15.6M | +59.2% |
| Pre-tax Income | $16.2M | +64.5% |
| Income Tax | $3.4M | +556.3% |
| Net Income | $12.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.0M | -6.5% |
| Accounts Receivable | $13.3M | +158.4% |
| Inventory | $5.4M | +24.9% |
| Current Assets | $77.5M | +1.6% |
| Total Assets | $85.5M | +3.2% |
| Current Liabilities | $8.6M | +25.4% |
| Total Liabilities | $11.8M | +10.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.0M | -10.8% |
| Capital Expenditures | $823K | +70.6% |
| Investing Cash Flow | -$1.4M | -312.1% |
| Financing Cash Flow | -$12.7M | — |
| Free Cash Flow | $9.2M | -14.4% |
| +37.6% |
| EPS (Basic) | $1.02 | +34.2% |
| EPS (Diluted) | $1.02 | +37.8% |
| Stockholders' Equity |
| $73.7M |
| +2.1% |